This study not only expands our knowledge on DSF by demonstrating its activities to suppress spontaneous fibrosarcoma metastasis and to up-regulate RECK but also strengthen our notion that the Reck-promoter-reporter assay may be useful in finding new types of anticancer therapeutics, including agents with low toxicity in vivo and with anti-metastatic activity. This evidence concerns the gene RECK and fibrosarcoma.